BackAcadia Pharmaceuticals Overview

Acadia Pharmaceuticals Other Income Expense Net

Other Income/Expense Net for ACAD.

Quarterly Other Income/Expense

$8.60M
↑ 1.27% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

$34.20M
↑ 14.09% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin